We have discussed in prior posts the unique regulatory enforcement climate that providers and investors currently find themselves. It is critical that anyone contemplating investment in a healthcare business not only understand the regulatory risks and pressures of that industry but carefully review
Compliance Plans Under the PPACA: One More Reason for Careful Compliance Program Analysis
By Amber Walsh on
Now more than ever, it is critical that anyone contemplating investment in a healthcare sector carefully review the target company’s compliance protocols. We have always strongly recommended that investors analyze the company’s compliance program, as well as efforts at adhering to…